Correction to: M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway
Cell Death Differ. 2023 Mar;30(3):856.
doi: 10.1038/s41418-022-01075-z.
1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
2 Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, PR China.
3 Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
4 Department of Pharmacology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
5 Department of Oncology, Yuhuangding Hospital, Yantai, Shangdong Province, PR China.
6 Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, PR China.
7 Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China. 346650985@qq.com.